Fig. 2
From: How mRNA therapeutics are entering the monoclonal antibody field
Schematic representation of optimized mRNA. The mRNA consists of different in cis-acting elements from 5′ to 3′: cap structure, 5′UTR, coding region with modified nucleotides, 3′ UTR and a poly-A tail
